Anti-Redness Clinical Study
1 other identifier
interventional
32
1 country
1
Brief Summary
This clinical study is a single-center, randomized, split-face, on-site controlled trial conducted at Shanghai China-Norm Quality Technical Service Co., Ltd. The primary objective is to evaluate the efficacy of Eucerin Ultrasensitive Repair Intensive Source Serum in providing instant and long-lasting (24-hour) soothing and repairing effects under induced redness conditions. The design involves recruiting 30 healthy Chinese female subjects aged 18-60 years, who meet stringent inclusion/exclusion criteria, including absence of skin conditions and no recent participation in similar studies. Redness is induced using 50% Glycolic Acid on the entire face and tape stripping on both forearms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 24, 2024
CompletedFirst Submitted
Initial submission to the registry
September 11, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedOctober 1, 2025
September 1, 2025
7 days
September 11, 2025
September 22, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Skin Erythema Index via Mexameter® MX 18
From Baseline to 24-hour after product repeat application
Colorimetry (avalue) via Chromameter CM26dG *
from Baseline to 24-hour after product repeat application
Skin Scaliness (Desquamation) via Squamescan® 850A
from Baseline to 24-hour after product repeat application
Forearm Skin Redness (avalue) via Cross-Polarized Light Imaging *
The a\*value is a parameter in the CIELAB color space (also known as Lab) that quantifies a color's position along the red-green axis .
From Baseline to 24-hour after product repeat application
Facial Skin Redness and Colorimetry (a* value) via VISIA-CRP Imaging
from Baseline to 24-hour after product repeat application
Skin Surface Evenness (SEsc) via UV Video Capture and SELS Analysis
from Baseline to 24-hour after product repeat application
Study Arms (4)
Facial Test Arm
OTHERFacial Control Arm
NO INTERVENTIONArm Test Arm
OTHERArm Control Arm
NO INTERVENTIONInterventions
The trained technician will apply the 0.3g-0.4g investigational products on the subject's half face.
The trained technician will apply the (2mg±0.1mg)/cm² investigational products on the subject's forearm.
Eligibility Criteria
You may qualify if:
- Chinese female whose age range from 18 to 60 years old;
- Be in general good health and good mental state;
- Have no any broken,scars,birthmarks and other imperfections on the test area;
- Redness/erythema≥grade 2 after modelling inducing and the score of redness must be increased after inducing;
- Not currently be participating in any other study involving the test area(Face and Forearm);
- Not have participated in any other study involving the test area in the past one month;
- Be willing to read,understand and able to sign the Informed Consent Form and Photo Release From;
- Be willing to comply with all study protocol requirements.
You may not qualify if:
- Intending to get pregnant, be pregnant, be lactating, be within 6 months of delivery or be unwilling to take necessary precautions to avoid a pregnancy;
- Having used antihistamine drugs in the past 1 week or immunosuppressants in the past 1 month;
- Taken anti-allergic drug/injections in the past 1 month;
- Presently have allergies, allergic dermatitis or skin disease;
- Have sensitivity or even allergy to topical products, ingredients or fragranced products;
- Have history of allergies;
- Have history of suffering from skin diseases (such as psoriasis, eczema, skin cancer, etc.);
- Have used any anti-inflammatory treatment on the test area within 2 months prior to this study starting date;
- Has a chronic medical condition that may interfere with testing (e.g., asthma, insulin-dependent diabetes, lupus, rheumatoid arthritis or other immune/auto-immune diseases);
- Have used any scrubs or peeling product (regardless of method) or self-tanning products or oil control products in the past 3 days;
- Have received cosmetic medical procedures on the face (such as injectable anti-wrinkle products, cosmetic surgery, tattoo removal, home light facial procedures or home use medical devices, etc.) in the past 1 month;
- Have excessive sun exposure or ultraviolet light exposure in the past 1 month;
- Have applied ortho-hydroxybenzoic acid, hydroquinone in the past 3 months; or used prescriptions (such as antibiotic, retinoids, alpha hydroxyl acid and steroid), oral contraceptives;
- Avoid providing emergency contact;
- Subjects that are not compliant with the selection criteria or not proper for participation as determined by Principal Investigator;
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ChinaNormlead
Study Sites (1)
Shanghai China-norm Quality Technical Service Co., Ltd.
Shanghai, Shanghai Municipality, 200072, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2025
First Posted
October 1, 2025
Study Start
January 15, 2024
Primary Completion
January 22, 2024
Study Completion
January 24, 2024
Last Updated
October 1, 2025
Record last verified: 2025-09